Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Research output: Contribution to journal › Review › Research › peer-review
Standard
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. / Andersen, Jens V.; Markussen, Kia H.; Jakobsen, Emil; Schousboe, Arne; Waagepetersen, Helle S.; Rosenberg, Paul A.; Aldana, Blanca I.
In: Neuropharmacology, Vol. 196, 108719, 2021.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
AU - Andersen, Jens V.
AU - Markussen, Kia H.
AU - Jakobsen, Emil
AU - Schousboe, Arne
AU - Waagepetersen, Helle S.
AU - Rosenberg, Paul A.
AU - Aldana, Blanca I.
N1 - Funding Information: The Scholarship of Peter & Emma Thomsen is gratefully acknowledged for personal financial support to JVA. PAR was supported by NIH grants NS066019 , MH104318 , EY027881 , HD018655 . Publisher Copyright: © 2021 The Authors
PY - 2021
Y1 - 2021
N2 - Glutamate is the primary excitatory neurotransmitter of the brain. Cellular homeostasis of glutamate is of paramount importance for normal brain function and relies on an intricate metabolic collaboration between neurons and astrocytes. Glutamate is extensively recycled between neurons and astrocytes in a process known as the glutamate-glutamine cycle. The recycling of glutamate is closely linked to brain energy metabolism and is essential to sustain glutamatergic neurotransmission. However, a considerable amount of glutamate is also metabolized and serves as a metabolic hub connecting glucose and amino acid metabolism in both neurons and astrocytes. Disruptions in glutamate clearance, leading to neuronal overstimulation and excitotoxicity, have been implicated in several neurodegenerative diseases. Furthermore, the link between brain energy homeostasis and glutamate metabolism is gaining attention in several neurological conditions. In this review, we provide an overview of the dynamics of synaptic glutamate homeostasis and the underlying metabolic processes with a cellular focus on neurons and astrocytes. In particular, we review the recently discovered role of neuronal glutamate uptake in synaptic glutamate homeostasis and discuss current advances in cellular glutamate metabolism in the context of Alzheimer's disease and Huntington's disease. Understanding the intricate regulation of glutamate-dependent metabolic processes at the synapse will not only increase our insight into the metabolic mechanisms of glutamate homeostasis, but may reveal new metabolic targets to ameliorate neurodegeneration.
AB - Glutamate is the primary excitatory neurotransmitter of the brain. Cellular homeostasis of glutamate is of paramount importance for normal brain function and relies on an intricate metabolic collaboration between neurons and astrocytes. Glutamate is extensively recycled between neurons and astrocytes in a process known as the glutamate-glutamine cycle. The recycling of glutamate is closely linked to brain energy metabolism and is essential to sustain glutamatergic neurotransmission. However, a considerable amount of glutamate is also metabolized and serves as a metabolic hub connecting glucose and amino acid metabolism in both neurons and astrocytes. Disruptions in glutamate clearance, leading to neuronal overstimulation and excitotoxicity, have been implicated in several neurodegenerative diseases. Furthermore, the link between brain energy homeostasis and glutamate metabolism is gaining attention in several neurological conditions. In this review, we provide an overview of the dynamics of synaptic glutamate homeostasis and the underlying metabolic processes with a cellular focus on neurons and astrocytes. In particular, we review the recently discovered role of neuronal glutamate uptake in synaptic glutamate homeostasis and discuss current advances in cellular glutamate metabolism in the context of Alzheimer's disease and Huntington's disease. Understanding the intricate regulation of glutamate-dependent metabolic processes at the synapse will not only increase our insight into the metabolic mechanisms of glutamate homeostasis, but may reveal new metabolic targets to ameliorate neurodegeneration.
KW - Alzheimer's disease (AD)
KW - Aspartate aminotransferase (AAT)
KW - Glutamate dehydrogenase (GDH)
KW - Glutamate-glutamine cycle
KW - Glutamic acid
KW - Huntington's disease (HD)
KW - Malate-aspartate shuttle (MAS)
KW - Neurotransmitter recycling
U2 - 10.1016/j.neuropharm.2021.108719
DO - 10.1016/j.neuropharm.2021.108719
M3 - Review
C2 - 34273389
AN - SCOPUS:85113725815
VL - 196
JO - Neuropharmacology
JF - Neuropharmacology
SN - 0028-3908
M1 - 108719
ER -
ID: 285939647